DK2834643T3 - Fremgangsmåde til behandling af blod, blodprodukter og organer - Google Patents
Fremgangsmåde til behandling af blod, blodprodukter og organer Download PDFInfo
- Publication number
- DK2834643T3 DK2834643T3 DK13718522.9T DK13718522T DK2834643T3 DK 2834643 T3 DK2834643 T3 DK 2834643T3 DK 13718522 T DK13718522 T DK 13718522T DK 2834643 T3 DK2834643 T3 DK 2834643T3
- Authority
- DK
- Denmark
- Prior art keywords
- blood
- bodies
- treating
- products
- blood products
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000010836 blood and blood product Substances 0.000 title 1
- 229940125691 blood product Drugs 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Psychology (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201210102999 DE102012102999A1 (de) | 2012-04-05 | 2012-04-05 | Verfahren zur Behandlung von Blut, Blutprodukten und Organen |
| DE102012108599.4A DE102012108599B4 (de) | 2012-09-14 | 2012-09-14 | A-Beta-Oligomer-bindende Peptide und deren Verwendung |
| DE102012108598.6A DE102012108598A1 (de) | 2012-09-14 | 2012-09-14 | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| PCT/EP2013/057160 WO2013150126A2 (de) | 2012-04-05 | 2013-04-05 | Verfahren zur behandlung von blut, blutprodukten und organen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2834643T3 true DK2834643T3 (da) | 2020-02-03 |
Family
ID=48184148
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13718522.9T DK2834643T3 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
| DK17172222.6T DK3260865T5 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17172222.6T DK3260865T5 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9591845B2 (https=) |
| EP (2) | EP3260865B1 (https=) |
| JP (3) | JP2015518474A (https=) |
| CN (2) | CN104380110A (https=) |
| DK (2) | DK2834643T3 (https=) |
| ES (2) | ES2938886T3 (https=) |
| PL (1) | PL3260865T3 (https=) |
| WO (1) | WO2013150126A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2834644B1 (de) | 2012-04-05 | 2019-08-21 | Forschungszentrum Jülich GmbH | Polymere, enthaltend multivalente amyloid-beta-bindende d-peptide und deren verwendung |
| DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| DK2834643T3 (da) | 2012-04-05 | 2020-02-03 | Forschungszentrum Juelich Gmbh | Fremgangsmåde til behandling af blod, blodprodukter og organer |
| DE102013016002A1 (de) * | 2013-09-26 | 2015-03-26 | Forschungszentrum Jülich GmbH | Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung |
| EP3747454B9 (de) | 2013-09-26 | 2023-10-04 | Priavoid GmbH | Amyloid-beta-bindende peptide und diese peptide zur verwendung für die therapie und die diagnose der alzheimerschen demenz |
| DE102015003676A1 (de) * | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH Fachbereich Patente | Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz |
| WO2018009514A1 (en) * | 2016-07-06 | 2018-01-11 | George Stantchev | Apparatus and method for plant extraction |
| JP7429343B2 (ja) | 2018-01-05 | 2024-02-08 | パス イーエックス，インク． | 流体からの疾患材料の捕捉および除去のためのデバイス |
| GB201904810D0 (en) * | 2019-04-05 | 2019-05-22 | Cynapsedx Ltd | The treatment of protein aggregation diseases |
| JP7774972B2 (ja) * | 2021-04-01 | 2025-11-25 | 禎弘 飯田 | ペプチド結合切断活性を有する人工ペプチドおよびその利用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854204A (en) | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
| US5968820A (en) | 1997-02-26 | 1999-10-19 | The Cleveland Clinic Foundation | Method for magnetically separating cells into fractionated flow streams |
| US6384105B1 (en) | 1999-04-16 | 2002-05-07 | William Marsh Rice University | Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol) |
| ATE355374T1 (de) | 2000-11-27 | 2006-03-15 | Praecis Pharm Inc | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen |
| DE10117281A1 (de) | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
| US20040143093A1 (en) * | 2002-07-11 | 2004-07-22 | Ralph Zahn | Method for inducing a conformational transition in proteins, such as pathogenic/infectious proteins, and their use |
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| US20050158306A1 (en) | 2004-01-16 | 2005-07-21 | Halikas James A. | Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| DE102005009909A1 (de) | 2005-03-01 | 2006-09-07 | Heinrich-Heine-Universität Düsseldorf | Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine |
| DE102005031429A1 (de) | 2005-07-04 | 2007-01-11 | Heinrich-Heine-Universität Düsseldorf | Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen |
| DE102005063175A1 (de) | 2005-07-29 | 2007-02-01 | Hans-Werner Prof. Dr. Heinrich | Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung für Tiere, in der Biotechnologie (einschließlich der biologischen Forschung) und der medizinischen Diagnostik |
| US20070092508A1 (en) * | 2005-10-21 | 2007-04-26 | Recombiant Technologies, Llc | Detoxification depot for Alzheimer's disease |
| DE102006015140A1 (de) | 2006-03-31 | 2007-10-11 | Philipps-Universität Marburg | Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen |
| JP2010521526A (ja) | 2007-03-23 | 2010-06-24 | ザ・ガバナーズ・オブ・ザ・ユニバーシティー・オブ・アルバータ | 多価ヘテロ二官能性ポリマーおよびその使用方法 |
| CN101538329B (zh) * | 2008-03-20 | 2013-01-30 | 中国医学科学院基础医学研究所 | 新的抗β-淀粉样多肽抗体的可变区序列及其编码序列 |
| WO2010062570A2 (en) * | 2008-10-27 | 2010-06-03 | Recombinant Technologies Llc | COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE |
| DE102008037564A1 (de) * | 2008-11-19 | 2010-05-20 | Forschungszentrum Jülich GmbH | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
| DE102009037015A1 (de) | 2009-08-07 | 2011-02-17 | Michael Hajek | Vorrichtung und Verfahren zur Eliminierung von bioschädlichen Stoffen aus Körperflüssigkeiten |
| DE102010019336A1 (de) | 2010-05-05 | 2011-11-10 | Forschungszentrum Jülich GmbH | Mittel zur Behandlung der Alzheimerschen Demenz |
| DE102010017130B4 (de) * | 2010-05-28 | 2018-11-29 | Forschungszentrum Jülich GmbH | Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung |
| CN102233128B (zh) * | 2010-11-26 | 2013-04-17 | 王延江 | 一种p75NTR-ECD在防治阿尔茨海默病药物中应用 |
| EP2834644B1 (de) | 2012-04-05 | 2019-08-21 | Forschungszentrum Jülich GmbH | Polymere, enthaltend multivalente amyloid-beta-bindende d-peptide und deren verwendung |
| DK2834643T3 (da) * | 2012-04-05 | 2020-02-03 | Forschungszentrum Juelich Gmbh | Fremgangsmåde til behandling af blod, blodprodukter og organer |
-
2013
- 2013-04-05 DK DK13718522.9T patent/DK2834643T3/da active
- 2013-04-05 ES ES17172222T patent/ES2938886T3/es active Active
- 2013-04-05 US US14/388,865 patent/US9591845B2/en active Active
- 2013-04-05 CN CN201380018312.9A patent/CN104380110A/zh active Pending
- 2013-04-05 PL PL17172222.6T patent/PL3260865T3/pl unknown
- 2013-04-05 DK DK17172222.6T patent/DK3260865T5/da active
- 2013-04-05 ES ES13718522T patent/ES2773125T3/es active Active
- 2013-04-05 EP EP17172222.6A patent/EP3260865B1/de active Active
- 2013-04-05 JP JP2015503890A patent/JP2015518474A/ja active Pending
- 2013-04-05 EP EP13718522.9A patent/EP2834643B1/de active Active
- 2013-04-05 WO PCT/EP2013/057160 patent/WO2013150126A2/de not_active Ceased
- 2013-04-05 CN CN201810884744.2A patent/CN108926749A/zh active Pending
-
2017
- 2017-02-15 US US15/433,143 patent/US10123530B2/en active Active
- 2017-07-10 JP JP2017134929A patent/JP6619394B2/ja active Active
-
2018
- 2018-10-23 US US16/167,615 patent/US10772321B2/en active Active
-
2019
- 2019-11-14 JP JP2019206147A patent/JP6997160B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2834643A2 (de) | 2015-02-11 |
| JP6619394B2 (ja) | 2019-12-11 |
| US20170172139A1 (en) | 2017-06-22 |
| US10772321B2 (en) | 2020-09-15 |
| JP2015518474A (ja) | 2015-07-02 |
| EP3260865A3 (de) | 2018-05-09 |
| US20150282477A1 (en) | 2015-10-08 |
| US9591845B2 (en) | 2017-03-14 |
| EP2834643B1 (de) | 2019-10-23 |
| ES2938886T3 (es) | 2023-04-17 |
| DK3260865T3 (da) | 2023-02-27 |
| ES2773125T3 (es) | 2020-07-09 |
| US20190037835A1 (en) | 2019-02-07 |
| US10123530B2 (en) | 2018-11-13 |
| JP2020037582A (ja) | 2020-03-12 |
| WO2013150126A2 (de) | 2013-10-10 |
| CN104380110A (zh) | 2015-02-25 |
| JP2017222682A (ja) | 2017-12-21 |
| WO2013150126A3 (de) | 2014-01-03 |
| PL3260865T3 (pl) | 2023-04-11 |
| EP3260865B1 (de) | 2022-12-28 |
| DK3260865T5 (da) | 2024-10-14 |
| JP6997160B2 (ja) | 2022-02-03 |
| CN108926749A (zh) | 2018-12-04 |
| EP3260865A2 (de) | 2017-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2834643T3 (da) | Fremgangsmåde til behandling af blod, blodprodukter og organer | |
| DK3821830T3 (da) | Anordning og fremgangsmåde til behandling af vaskulær okklusion | |
| IL290993A (en) | Methods of diagnosing and treating tourette syndrome | |
| DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
| DK4000608T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
| DK3295942T3 (da) | Kombinationer omfattende 5-phenoxy-3h-pyrimidin-4-on-derivater og anvendelse heraf til profylakse eller behandling af hiv-infektion | |
| BR112014020761A2 (pt) | Aparelho médico e método | |
| DK3252160T3 (da) | Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation | |
| EP2755736A4 (en) | APPARATUS, SYSTEM AND METHODS FOR TREATING FLUID | |
| DK2699553T3 (da) | Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK2776567T3 (da) | Sammensætninger og fremgangsmåder til behandling af cytomegalovirus. | |
| DK3074544T3 (da) | Martensitholdigt rustfrit stål, stykke udført i dette stål og fremgangsmåde til fremstilling heraf | |
| DK2903967T3 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme | |
| BR112013034056A2 (pt) | método e aparelho de processamento de entradas | |
| DK2898865T3 (da) | Pleje-fremgangsmåde og plejerobot, der anvendes ved denne | |
| BR112014025507A2 (pt) | formulação vesicular e método de tratamento | |
| DK3434276T3 (da) | Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft | |
| BR112014017038A8 (pt) | método, e aparato | |
| DK2911844T3 (da) | Opslæmningsfordeler, system og fremgangsmåde til anvendelse deraf | |
| DK2968205T3 (da) | Produkt og fremgangsmåde til behandling af diarré | |
| DK2780059T3 (da) | Medicinsk anordning og fremgangsmåde til begrænsning af anvendelsen af den medicinske anordning | |
| DK2882863T3 (da) | System og fremgangsmåde til kvantitativ billeddannelse af mitokondriekompleks 1 | |
| DK2892556T3 (da) | Sammensætninger og fremgangsmåder til behandling af sygdomme | |
| BR112013034066A2 (pt) | método de administração e tratamento |